Stem Cell Therapy Market to reach USD 1,113.12 million by 2032 and grow at a CAGR of 17.10%
The lifted burden of chronic diseases has resulted in the advancement of regenerative stem cell therapy which is being investigated as a good therapeutic agent for these fatal disorders. As an illustration, in December 2023 Mayo Clinic researchers and international collaborators showed that the propagation of stem cell-based regenerative therapy was effective for advanced heart failure.